Presentations: Leipzig Interventional Course – interdisciplinary global platform for endovascular interventions

Main Arena 1

34 events

Monday, June 6th: 13:00 - 14:15, Main Arena 1

New solutions for complex aortoiliac obstructions

Moderator:

Dierk Scheinert

Panel:

Patrice Mwipatayi, Maria Antonella Ruffino, Peter Goverde, Eric Secemsky
1. 13:00 - 13:15
  
  Live case transmission from Leipzig – part I
2. 13:15 - 13:20
  
  Use and effectiveness of Pioneer re-entry device for subintimal true lumen re-entry: Single-centre data and a review of the literature
3. 13:20 - 13:25
  
  Initial interim results from the post-market registry of the GORE® VIABAHN® VBX balloon expandable endoprosthesis implanted in peripheral vessels
4. 13:25 - 13:30
  
  Following up patients with iliac occlusive disease treated with the GORE® VIABAHN® VBX balloon expandable endoprosthesis – FLEX clinical study
5. 13:30 - 13:35
  
  Outcomes of self-expanding e-PTFE covered stent when treating chronic iliac artery occlusions – a multi-centre experience
6. 13:35 - 13:45
  
  Live case transmission from Leipzig – part II
7. 13:45 - 13:50
  
  Versatility of covered stents in complex aorto-iliac POD lesions and FEVAR/BEVAR
8. 13:50 - 13:55
  
  FIRST TIME DATA RELEASE: BELSTREAM – 12-month results of study
9. 13:55 - 14:00
  
  5-year follow-up of CERAB reconstructions: Single center experience from the Netherlands
10. 14:00 - 14:05
  
  Multicentre experience on CERAB technique for the treatment option of AIOD – Polish experiences
11. 14:05 - 14:10
  
  Improving outcomes of vascular interventions with AI
12. 14:10 - 14:15
  
  Advances in intravascular imaging: Real world evidence and expert consensus
Monday, June 6th: 14:15 - 15:15, Main Arena 1

Opening Symposium: Focus on the lower limb: Novel treatment options from SFA to BTK

supported by Abbott Vascular

Moderator:

Dierk Scheinert

Panel:

Luis Palena, Michael Lichtenberg, Houman Jalaie, Lieven Maene
1. 14:15 - 14:17
  
  Welcome from the moderator
2. 14:17 - 14:29
  
  Late breaker: 2 year follow-up of SUPERSUB II
3. 14:29 - 14:34
  
  Discussion
4. THROMBECTOMY: THE BENEFITS OF MECHANICAL THROMBECTOMY FOR LOWER LIMB TREATMENT
5. 14:34 - 14:39
  
  Treating acute limb ischemia with mechanical thrombectomy – case presentation
6. 14:39 - 14:46
  
  Mechanical thrombectomy for venous thromboembolism: A pathway to consider?
7. 14:46 - 14:51
  
  Treating venous thromboembolism with mechanical thrombectomy – case presentation
8. 14:51 - 14:58
  
  Discussion
9. 14:58 - 15:08
  
  Tomorrow’s BTK treatment options – drug eluting resorbable scaffolds
10. 15:08 - 15:13
  
  Discussion
11. 15:13 - 15:15
  
  Take-home messages
Monday, June 6th: 15:15 - 16:30, Main Arena 1

Novel approaches and insights for treatment of complex femoropopliteal disease – part I

Moderator:

Thomas Zeller, Peter Schneider

Panel:

Gary Ansel, Koen Deloose, Robert Beasley, Erwin Blessing, Rokas Gircius, Peter Metzger
1. 15:15 - 15:20
  
  Serration angioplasty technique for better lumen gain
2. 15:20 - 15:30
  
  RECORDED CASE PRESENTATION: Serranator Serration balloon as primary therapy for CLTI disease
3. 15:30 - 15:35
  
  FIRST TIME DATA RELEASE: UltraScore – final results of a multi-center study
4. 15:35 - 15:40
  
  FIRST TIME DATA RELEASE: Long-term evidence of directonal atherectomy and DCB: 3-year clinical experience from Australia
5. 15:40 - 15:45
  
  Clinical outcomes with drug-coated balloon alone vs. drug-coated balloon plus provisional stenting: An analysis from the IN.PACT global study 5-year data
6. 15:45 - 15:50
  
  BIOPACT RCT: A head-to-head multicenter noninferiority trial of the safety and efficacy of Passeo-18 Lux vs. In.Pact Admiral DCBs in fempop lesions
7. 15:50 - 16:05
  
  Live case transmission from Bad Krozingen
8. 16:05 - 16:15
  
  FIRST TIME DATA RELEASE: Cost-effectiveness of urea excipient-based drug-coated balloons for chronic limb-threatening ischemia from femoropopliteal disease
9. 16:15 - 16:20
  
  5-year results from the Lutonix trial
10. 16:20 - 16:25
  
  IN.PACT global study 5-year diabetic and gender subgroup outcomes
11. 16:25 - 16:30
  
  Recent data outcomes in complex femoropopliteal occlusive disease with the GORE® VIABAHN® Endoprosthesis
Monday, June 6th: 16:30 - 17:15, Main Arena 1

Status of the SFA treatment paradigm

supported by COOK Medical

Moderator:

Koen Deloose

Panel:

Aloke Finn, Thomas Zeller, Osamu Iida, Marc Bosiers, E. Sebastian Debus
1. POLYMER-COATED DES: LEARN ABOUT THE EVIDENCE
2. 16:30 - 16:36
  
  Pre-clinical experience
3. 16:36 - 16:42
  
  Clinical experience
4. 16:42 - 16:48
  
  Clinical experience
5. 16:48 - 16:55
  
  Q&A, discussion
6. ADDITIONAL BENEFITS OF ENDOVASCULAR TREATMENT OVER BYPASS – READY TO MOVE ON?
7. 16:55 - 17:01
  
  Zilverpass – 36-month update and health economic snapshot
8. 17:01 - 17:07
  
  Should the endovascular approach be the new frontier?
9. 17:07 - 17:15
  
  Q&A, discussion, and conclusion
Monday, June 6th: 17:15 - 19:00, Main Arena 1

Novel approaches and insights for treatment of complex femoropopliteal disease – part II

Moderator:

Koen Deloose, Yann Gouëffic

Panel:

Marianne Brodmann, Antonio Micari, John Laird, Gireesh Mukund Warawdekar
1. 17:15 - 17:20
  
  Optimizing PTA following atherectomy in complex lower limb lesions: 12-month results of the DISSECT study
2. 17:20 - 17:25
  
  FIRST TIME DATA RELEASE: Treating common femoral artery steno-occlusive lesions with an endovascular approach using DA+DCB: 3-year follow-up in 75 patients
3. 17:25 - 17:45
  
  Live case transmission from Leipzig
4. 17:45 - 17:50
  
  Safety, effectiveness, and mid-term follow-up in 400 consecutive patients with moderate to severely calcified lesions undergoing phoenix atherectomy
5. 17:50 - 17:55
  
  Directional atherectomy (DA) followed by DCB to treat long, calcified femoropopliteal artery lesions: The REALITY study
6. 17:55 - 18:00
  
  EMINENT RCT (Eluvia vs. BMS): 12-month primary endpoint data and subset analysis
7. 18:00 - 18:05
  
  MIMICS-3D 3-year results: Compelling clinical outcomes with BioMimics 3D in complex patients and lesions
8. 18:05 - 18:10
  
  TINTIN trial 3-year follow-up
9. 18:10 - 18:40
  
  Live case transmission from Münster
10. 18:40 - 18:45
  
  FIRST TIME DATA RELEASE: Predictors of drug-coated balloon efficacy in femoropopliteal intervention: Insights from a patient-level pooled analysis
11. 18:45 - 18:50
  
  5-year results from the IN.PACT global study pre-specified cohorts: In-stent restenosis, chronic total occlusions, and long lesions
12. 18:50 - 18:55
  
  Safety and efficacy of Passeo-18 Lux in long lesions: Pooled results from the BIOLUX P-III and BIOLUX P-III Spain studies
13. 18:55 - 19:00
  
  Stellarex complex lesion subset analysis from the SAVER real world registry
Tuesday, June 7th: 8:00 - 9:15, Main Arena 1

CONNECT THE WORLD JAPAN: Pioneering approaches for CTO treatment in peripheral arteries

partially supported by Boston Scientific

Moderator:

Dierk Scheinert, Hiroyoshi Yokoi

Panel:

Osamu Iida, Daizo Kawasaki, Koen Deloose, Ralf Langhoff

live from Tokyo:

Tatsuya Nakama

live from Leipzig:

Andrej Schmidt
1. FLASH PRESENTATION: The results from CAPSICUM multi-center registry of Eluvia DES in Japan
2. FLASH PRESENTATION: IVUS for peripheral interventions: Basic knowledge and tips and tricks
Tuesday, June 7th: 9:15 - 10:30, Main Arena 1

First time right! Optimizing acute to long-term outcomes in lower limb revascularisation

supported by Philips

Moderator:

Mark Portou, Michael Lichtenberg

Panel:

Konstantinos Stavroulakis, Ashish Patel, Marco Manzi
1. 09:15 - 09:22
  
  Accurate assessment – see better to treat better
2. 09:22 - 09:29
  
  Optimized vessel preparation – plaque disruption, ablation, and removal
3. 09:29 - 09:36
  
  Definitive therapy – the importance of focal dissection repair
4. 09:36 - 09:56
  
  Live case transmission from Münster
5. 09:56 - 10:30
  
  Discussion and conclusion
Tuesday, June 7th: 10:30 - 11:15, Main Arena 1

Real-world catheter-based reperfusion strategies for the treatment of acute DVT and PE

supported by Boston Scientific

Moderator:

Andrew Sharp

Panel:

Stefano Barco, Nils Kucher
1. 10:30 - 10:32
  
  Welcome and introduction
2. 10:32 - 10:44
  
  How I treat a patient presenting with iliofemoral DVT – rethro data on EKOS Angiojet
3. 10:44 - 10:56
  
  How I treat a patient presenting with pulmonary embolism – Zurich pathway
4. 10:56 - 11:08
  
  Present and future EKOS clinical data – KNOCOUT PE data and HiPeitho trial
5. 11:08 - 11:15
  
  Q&A, discussion, and conclusion
Tuesday, June 7th: 11:15 - 12:30, Main Arena 1

Endoluminal bypass for the treatment of complex lower limb disease

supported by W. L. Gore & Associates

Moderator:

Michel Reijnen

Panel:

Michele Piazza, Christian Habermann
1. 11:15 - 11:20
  
  Introduction from the moderator
2. 11:20 - 11:35
  
  Iliac: Your TASC II C&D patients – the value of covered stents in treating AIOD
3. 11:35 - 11:45
  
  Live case transmission from Leipzig
4. 11:45 - 12:00
  
  SFA: Strengthening clinical performance in your most challenging patients – the treatment options and the data by Michel Reijnen
5. 12:00 - 12:15
  
  SFA: Strengthening clinical performance in your most challenging patients –case presentation by Christian Habermann
6. 12:15 - 12:25
  
  Live case revisited
7. 12:25 - 12:30
  
  Q&A, discussion, and conclusion
Tuesday, June 7th: 12:30 - 13:15, Main Arena 1

LUNCH SYMPOSIUM: BTK controversies – how would you treat?

supported by Abbott Vascular

Moderator:

Koen Deloose

Panel:

Lieven Maene, Tobias Koppara
1. 12:30 - 12:33
  
  Opening/session objectives
2. 12:33 - 12:43
  
  Below-the-knee: Access and vessel preparation – how would you do it?
3. 12:43 - 12:48
  
  Discussion
4. 12:48 - 12:58
  
  Below-the-knee: How intravascular imaging could make a difference
5. 12:58 - 13:03
  
  Discussion
6. 13:03 - 13:13
  
  Below-the-knee: Optimal treatment now and in the future?
7. 13:13 - 13:15
  
  Discussion and conclusion
Tuesday, June 7th: 13:30 - 14:45, Main Arena 1

SYMPOSIUM: Directional atherectomy plus drug-coated balloons to treat long, calcified femoropopliteal artery lesions: Current data and a live case

supported by Medtronic

Moderator:

Dierk Scheinert

Panel:

Thomas Zeller, Antonio Micari
1. 13:30 - 13:40
  
  IN.PACT Admiral DCB for the treatment of long/complex lesions
2. 13:40 - 13:50
  
  The REALITY study 12-month results
3. 13:50 - 14:40
  
  Live case transmission from Leipzig
4. 14:40 - 14:45
  
  Q&A, discussion, and conclusion
Tuesday, June 7th: 14:45 - 15:30, Main Arena 1

Low-profile access and new access routes for peripheral arterial procedures

Moderator:

Jos van den Berg

Panel:

Yann Gouëffic, Eugenio Stabile, Marcus Thieme, Lieven Maene, Luis Palena
1. 14:45 - 14:50
  
  The cost savings and avoided complications of low-profile 4F interventions
2. 14:50 - 15:25
  
  Live case transmission from Münster
3. 15:25 - 15:30
  
  Are we ready for a new approach to iliac lesions? Benefits and limitations to radial access for iliac stenting
Tuesday, June 7th: 15:30 - 16:00, Main Arena 1

FOCUS SESSION: The emerging value of out-of-hospital sites of care

supported by Philips

Moderator:

Dierk Scheinert

Panel:

Foluso Fakorede, Janice Tsui, Ounali Jaffer
1. 15:30 - 15:40
  
  Lessons learned in providing out of hospital care in a remote, underserved region of Mississippi
2. 15:40 - 16:00
  
  Panel discussion
Tuesday, June 7th: 16:00 - 16:45, Main Arena 1

Save a limb to save a life – new horizons with Sirolimus eluting balloons in treating CLI patients – global experience

a case based discussion, supported by Medalliance

Moderator:

Michael Lichtenberg

Panel:

Bella Huasen, Tjun Tang, Luis Palena, Ehrin Armstrong
1. 16:00 - 16:10
  
  SELUTION SLR Sirolimus eluting balloon technology: Why does it matter to our patients?
2. 16:10 - 16:20
  
  Case 1: A CLI/BTK patient from Singapore – Asian experience
3. 16:20 - 16:30
  
  Case 2: A CLI/BTK patient from Italy – European experience
4. 16:30 - 16:40
  
  Next stop USA – latest update on the SELUTION4BTK IDE clinical trial
5. 16:40 - 16:45
  
  Discussion and conclusion
Tuesday, June 7th: 16:45 - 18:00, Main Arena 1

The challenge of calcification in BTK interventions

Moderator:

Luis Palena, Thomas Zeller

Panel:

Sean Lyden, Miguel Montero-Baker, Ehrin Armstrong, Ralf Langhoff, Roberto Ferraresi
1. 16:45 - 16:50
  
  Calcium definitions in endovascular clinical trials: Is the struggle real?
2. 16:50 - 16:55
  
  Small artery disease and medial artery calcification: The silent killer of the leg
3. 16:55 - 17:00
  
  Ultrasound based calcium score for the identification of no option CLTI
4. 17:00 - 17:20
  
  Live case transmission from Leipzig
5. 17:20 - 17:25
  
  FIRST TIME DATA RELEASE: Prestige pilot study: IVUS guided Phoenix atherectomy and Stellarex DCB angioplasty in BTK interventions. 12-month final data presentation
6. 17:25 - 17:30
  
  LIBERTY real world evidence on CLI and diabetic patients
7. 17:30 - 17:35
  
  OCT guided atherectomy for BTK-disease, clinical outcome in a prospective analysed patient cohort
8. 17:35 - 17:40
  
  Initial 50 patient experience with the Phoenix 1.5 mm atherectomy system
9. 17:40 - 17:45
  
  Orbital atherectomy in the foot arteries: Clinical results
10. 17:45 - 17:50
  
  What is the role of intravascular lithotripsy for infrapopliteal vessels?
11. 17:50 - 18:00
  
  Discussion and conclusion
Wednesday, June 8th: 8:00 - 9:00, Main Arena 1

CONNECT THE WORLD SESSION in collaboration with CEC: The state of art in SFA treatment insights from global experts

partially supported by Medtronic

Moderator:

Dierk Scheinert, Andrej Schmidt

Co-Moderator:

Zhong Chen, Weiguo Fu, Wei Guo
1. 08:00 - 08:05
  
  Opening
2. 08:05 - 08:35
  
  Live case transmission from Chengdu
3. 08:35 - 08:40
  
  How to optimize vessel preparation with the chocolate balloon
4. 08:40 - 08:45
  
  Complex SFA disease: Tackling calcium with Directional Atherectomy
5. 08:45 - 08:50
  
  IN.PACT Admiral DCB - Long term outcomes from the IN.PACT Admiral clinical program
6. 08:50 - 08:55
  
  How do drug-coated balloons perform in patients with critical limb ischemia? 5-year outcomes from the IN.PACT global study
7. 08:55 - 09:00
  
  Discussion and conclusion
Wednesday, June 8th: 9:00 - 9:30, Main Arena 1

ASK THE EXPERTS: Our personal tips and tricks with the interwoven nitinol stent

supported by Abbott Vascular

Moderator:

Ralf Langhoff, August Ysa, Lieven Maene
1. Panel discussion
Wednesday, June 8th: 9:30 - 10:15, Main Arena 1

Advanced techniques for challenging lesions

Moderator:

Dierk Scheinert

Panel:

Sabine Steiner, Edward Choke, Uei Pua
1. Live case transmission from Leipzig
2. Peripheral arterial vessel prepping with intravascular ultrasound and atherectomy – an interventionalist’s perspective
3. What does it take to optimise treatment of complex SFA lesions: Update on the BEST SFA trial
4. Outcomes of the covered self-expandable stents for the treatment of critical limb ischemia patients
Wednesday, June 8th: 10:15 - 11:00, Main Arena 1

SYMPOSIUM: IVL – consistently tackling severe calcium

supported by Shockwave

Moderator:

Konstantinos Stavroulakis

Panel:

Raphael Coscas, Narayanan Thulasidasan, Michel Bosiers
1. 10:15 - 10:25
  
  Embracing the challenges created by severe calcification
2. 10:25 - 10:35
  
  Simplicity and reliability: Consistent strategy produces predicable outcomes across multiple vessel beds
3. 10:35 - 10:45
  
  Reducing the risks spawned by calcium in CLTI patients
4. 10:45 - 10:55
  
  A paradigm shift in managing hostile access and facilitating endograft delivery
5. 10:55 - 11:00
  
  Q&A, discussion, and conclusion
Wednesday, June 8th: 11:00 - 11:45, Main Arena 1

Latest techniques for carotid revascularisation

Moderator:

Dierk Scheinert

Panel:

Piotr Musialek, Matteo Stefanini, Ralf Langhoff
1. 11:00 - 11:35
  
  Live case transmission from Leipzig
2. Micronet-covered stent in stroke prevention and treatment: New evidence
3. Mechanical properties and vessel adaptability of carotid stents: Could these change the procedural outcomes?
Wednesday, June 8th: 11:45 - 12:30, Main Arena 1

Standing on evidence in SFA intervention

supported by Boston Scientific

Moderator:

Marianne Brodmann, Antonio Micari

Panel:

Sabine Steiner, Yann Gouëffic, Giovanni Torsello
1. 11:45 - 11:48
  
  Introduction: The evolution of clinical trials in SFA
2. 11:48 - 11:54
  
  FLASH PRESENTATION: Highlights and insights of DCB level 1 evidence
3. 11:54 - 12:00
  
  FLASH PRESENTATION: Highlights and insights of DES level 1 evidence
4. 12:00 - 12:06
  
  FLASH PRESENTATION: Highlights and insights of real world evidence
5. 12:06 - 12:27
  
  Panel discussion and audience interaction – Why evidence generation matters – What does this mean for our SFA treatment algorithm? – What does this mean for our patients? – What does this mean for our hospital system?
6. 12:27 - 12:30
  
  Conclusion and close
Wednesday, June 8th: 12:30 - 13:15, Main Arena 1

LUNCH SYMPOSIUM: The Alvimedica drug approach to the treatment of lower limb lesions

supported by Alvimedica

Moderator:

Ralf Langhoff

Panel:

Andrea Kahlberg, Stefan Müller-Hülsbeck, Marco Manzi, Marc Sirvent
1. 12:30 - 12:32
  
  Introduction and objectives
2. 12:32 - 12:39
  
  Amphilimus™: not only a pure drug option
3. 12:39 - 12:46
  
  Focus on SFA: What we know and what we don’t know about the use of Sirolimus
4. 12:46 - 12:53
  
  Focus on SFA: The NiTiDES™ solution
5. 12:53 - 13:00
  
  Focus on BTK: DES role in the treatment of the lower limb lesions
6. 13:00 - 13:07
  
  Focus on BTK: My personal experience with Cre8™ BTK
7. 13:07 - 13:13
  
  Discussion
8. 13:13 - 13:15
  
  Take-home messages and closure
Wednesday, June 8th: 13:30 - 14:45, Main Arena 1

SYMPOSIUM: Every patient journey deserves innovative PAD solutions: Access, restore, sustain

supported by BD

Moderator:

Koen Deloose

Panel:

Theodosios Bisdas, Bruno Migliara
1. 13:30 - 13:55
  
  Live case transmission from Zurich
2. 13:55 - 14:08
  
  Challenging patient journey chapter II – complex femeropopliteal CTO
3. 14:08 - 14:20
  
  Rotational mechanical atherothrombectomy in EVAR limbs – preliminary data
4. 14:20 - 14:35
  
  Challenging patient journey chapter III – complex iliac lesion management
5. 14:35 - 14:45
  
  Panel discussion
Wednesday, June 8th: 14:45 - 16:00, Main Arena 1

SYMPOSIUM: Sirolimus coated balloon: The future of peripheral intervention

supported by Concept Medical

Moderator:

Dierk Scheinert

Panel:

Aloke Finn, Edward Choke, Ulf Teichgräber, Francesco Liistro, Sahil Parikh, Stefano Barco
1. 14:45 - 14:52
  
  Is Sirolimus is a better option for PAD treatment
2. 14:52 - 15:07
  
  XTOSI 2 year results and updates on FUTURE BTK & SFA
3. 15:07 - 15:22
  
  Case from SIRONA RCT and presentation on LIMES study design
4. 15:22 - 15:35
  
  DEBATE BTK duell study design and case presentation with FU
5. 15:35 - 15:50
  
  The SirPAD randomized trial at half of target enrolment: Study update and exemplary case treated with sirolimus-coated balloon
6. 15:50 - 16:00
  
  Discussion and conclusion
Wednesday, June 8th: 16:00 - 16:25, Main Arena 1

VIVA@LINC – CLTI from challenges to milestones and what is next? – Part I: Big picture trends in CLTI

Moderator:

Peter Schneider, Marianne Brodmann

Panel:

Joshua Beckman, Tony Das, Raghu Kolluri, Roberto Ferraresi, Ralf Langhoff
1. Announcement Vascular Carreer Award
2. 16:00 - 16:05
  
  The cost of CLTI: How many amputations occur each year and what is the cost to the patient and society?
3. 16:05 - 16:10
  
  What is new in imaging, functional assessment, and perfusion monitoring?
4. 16:10 - 16:15
  
  Emerging trends: Models for team care, standardizing wound management, and best practices for long-term care
5. 16:15 - 16:25
  
  Discussion
Wednesday, June 8th: 16:25 - 18:00, Main Arena 1

VIVA@LINC – CLTI from challenges to milestones and what is next? – Part II: New interventional approaches in CLTI

Moderator:

Peter Schneider, Marianne Brodmann

Panel:

Luis Palena, Venita Chandra, Koen Deloose, Ralf Langhoff, Roberto Ferraresi
1. 16:25 - 16:50
  
  Live case transmission from Kingsport, USA
2. 16:50 - 16:55
  
  How BTK alternative access techniques have changed my practice
3. 16:55 - 17:00
  
  Specialty balloons and atherectomy for BTK application: How to apply these for optimal lumen gain
4. 17:00 - 17:05
  
  Drug-coated balloons BTK: What is the evidence for Paclitaxel? What is the status of limus-based DCB?
5. 17:05 - 17:30
  
  Live case transmission from Leipzig
6. 17:30 - 17:35
  
  Current and future BTK scaffolds: Tacks, stents, and other novel scaffolds for BTK application
7. 17:35 - 17:40
  
  Alternative bypass techniques: Endovascular deep venous arterialization and detour procedures – where are we so far?
8. 17:40 - 18:00
  
  Discussion
Thursday, June 9th: 8:00 - 9:15, Main Arena 1

CONNECT THE WORLD SESSION in collaboration with JET – peripheral wiring techniques for CTO lesions

partially supported by Asahi Intecc

Moderator:

Roberto Ferraresi

Co-Moderator:

Hiroyoshi Yokoi

Panel:

Yoshimitsu Soga, Daniel van den Heuvel, Steven Kum, Koen Deloose

live from Amagasaki and Abano Terme:

Osamu Iida, Marco Manzi
1. FLASH PRESENTATION: Current status of CLTI
2. Live case transmission from Amagasaki
3. Live case transmission from Abano Terme
4. FLASH PRESENTATION: Antegrade wire escalation for BTK lesions
5. Live case transmission from Amagasaki
6. Live case transmission from Abano Terme
7. FLASH PRESENTATION: Distal puncture and retrograde looping wire technique
8. Live case transmission from Amagasaki – summary
9. Live case transmission from Abano Terme – summary
Thursday, June 9th: 9:15 - 10:30, Main Arena 1

Limb preservation masterclass: Cutting edge techniques and tools for CLTI

supported by COOK Medical

Moderator:

Jos van den Berg

Panel:

Marianne Brodmann, Marco Manzi
1. 09:15 - 09:40
  
  Live case transmission from Leipzig
2. 09:40 - 09:53
  
  The cost of endovascular limb preservation vs. amputation
3. 09:53 - 10:06
  
  The antegrade approach to CLTI and advanced CTO crossing strategies
4. 10:06 - 10:19
  
  Pedal artery revascularisation: The retrograde approach to CLTI and advanced CTO crossing strategies
5. 10:19 - 10:30
  
  Q&A, discussion, and conclusion
Thursday, June 9th: 10:30 - 11:15, Main Arena 1

New techniques and technologies for BTK interventions – latest data

Moderator:

Marianne Brodmann, Steven Kum

Panel:

Tatsuya Nakama, Francesco Liistro, Yoshimitsu Soga, Luis Palena, Michael Lichtenberg
1. 10:30 - 10:35
  
  Live case recap from first session
2. 10:35 - 10:40
  
  ACOART-BTK: 3-year clinical outcome
3. 10:40 - 10:45
  
  Current status and future of limus based drug coated balloons in the infrapopliteal arteries
4. 10:45 - 10:50
  
  Latest evidence for focal dissection repair with the Tack endovascular scaffold: Reviewing the 2-year TOBA II BTK data
5. 10:50 - 10:55
  
  When to stent tibial arteries: Update on abluminus sirolimus eluting stent trial
6. 10:55 - 11:00
  
  SAVAL DESK BTK: Current status
7. 11:00 - 11:05
  
  Current technology for BTK scaffolds
8. 11:05 - 11:10
  
  Bioresorbable scaffolds for BTK interventions (LIFE-BTK)
9. 11:10 - 11:15
  
  R3 vascular drug-eluting bioresorbable scaffold in below the knee vessels: Interim results from the RESOLV-I trial
Thursday, June 9th: 11:15 - 12:30, Main Arena 1

SYMPOSIUM: Redefining vascular treatment strategy for AVF and AVG: A deep dive into Sirolimus coated balloon

supported by Concept Medical

Moderator:

Tjun Tang

Panel:

Edward Choke, Gireesh Reddy, Chieh Suai Tan, Sanjay Misra
1. 11:15 - 11:27
  
  Advantages of Sirolimus over Paclitaxel for the treatment of AVF/AVG Stenosis
2. 11:27 - 11:37
  
  MATILDA 2 year follow up presentation and case presentation
3. 11:37 - 11:44
  
  Complex cases presentation AVG
4. 11:44 - 11:51
  
  2 year follow up on AVF in salvage of AVG study
5. 11:51 - 11:58
  
  Updates on IMPRESSION RCT and study design presentation
6. 11:58 - 12:05
  
  Complex cases presentation AVF
7. 12:05 - 12:12
  
  Magic Touch AVF – US FDA Study Design
8. 12:12 - 12:27
  
  Panel discussion
9. 12:27 - 12:30
  
  Conclusion
Thursday, June 9th: 12:30 - 13:25, Main Arena 1

LUNCH SYMPOSIUM: Innovations and new applications of embolization therapies

Moderator:

Walter A. Wohlgemuth, Romaric Loffroy

Panel:

Costantino del Giudice, Gloria Salazar, Clifford Weiss, Manuela Konert
1. 12:30 - 12:35
  
  Management of endoleaks via transarterial embolization with Onyx 34L
2. 12:35 - 12:40
  
  Contemporary peripheral aneurysm management: Techniques with fibered coils and micro vascular plugs
3. 12:40 - 12:50
  
  Recorded case presentation
4. 12:50 - 12:55
  
  French SEAL registry: Type II EndoLeak treatment outcomes using EVOH
5. 12:55 - 13:00
  
  Pulmonary AVMs: Deep dive into new data and guideline updates
6. 13:00 - 13:05
  
  Using liquids in trauma cases: Application of Onyx LES
7. 13:05 - 13:10
  
  Embolic selection for hemorrhoids: New application for coil technology
8. 13:10 - 13:15
  
  The CHRYSALIS study: First experience with the Caterpillar embolization device
9. 13:15 - 13:25
  
  Discussion and conclusion
Thursday, June 9th: 13:30 - 15:00, Main Arena 1

A comprehensive look at CLTI treatment: New approaches for assessment of CLTI and pioneering options for “No-hope-patients” – part I

Moderator:

Jos van den Berg, Marianne Brodmann

Panel:

Jihad Mustapha, William Gray, Roberto Ferraresi, Eric Ducasse, Peter Goverde
1. 13:30 - 13:35
  
  Hemodynamic vs. anatomical diagnosis of CLI
2. 13:35 - 13:55
  
  Live case transmission from Abano Terme – part I
3. 13:55 - 14:00
  
  Different types of atherosclerosis of the tibial arteries: Learn the histopathology
4. 14:00 - 14:05
  
  The role of vascular recoil in tibial arteries – the concept of the Choco Cabana study
5. 14:05 - 14:10
  
  Angiolite BTK trial: 2-year data in CLTI
6. 14:10 - 14:15
  
  Biblios trial: Investigating the safety and efficacy of the Luminor 14 DCB in the treatment of BTK lesions in real CLTI patients: Preliminary data (first 100 patients)
7. 14:15 - 14:20
  
  Remaining place for distal bypasses in BTK area
8. 14:20 - 14:40
  
  Live case transmission from Abano Terme – part II
9. 14:40 - 14:45
  
  Initial experience with the Microstent in tibial arteries – insights from the STAND trial
10. 14:45 - 14:50
  
  The Novel Temporary Spur stent system used in conjunction with a commercially available Paclitaxel balloon: 6-month results of the Deeper OUS trial
11. 14:50 - 14:55
  
  Dissection analysis after BTK-intervention with the Serranator device: A core-lab adjudicated study
12. 14:55 - 15:00
  
  CLTI – vascular recurrence. How to monitor and when to re-intervene
Thursday, June 9th: 15:00 - 15:45, Main Arena 1

SYMPOSIUM: WavelinQ™ EndoAVF System: An innovative patient centric solution

supported by BD

Moderator:

Tobias Steinke

Panel:

Panagiotis Kitrou, Ounali Jaffer, Fien Gryffroy
1. 15:00 - 15:07
  
  WavelinQ™ EndoAVF global clinical program, new and available evidence
2. 15:07 - 15:14
  
  Recorded case with WavelinQ™ EndoAVF System: The antiparallel option
3. 15:14 - 15:21
  
  Recorded case with WavelinQ™ EndoAVF System: The parallel option
4. 15:21 - 15:28
  
  Secondary procedures on EndoAVF: A practical approach
5. 15:28 - 15:45
  
  Panel discussion
Thursday, June 9th: 15:45 - 17:30, Main Arena 1

A comprehensive look at CLTI treatment: New approaches for assessment of CLTI and pioneering options for “No-hope-patients” – part II

Moderator:

Peter Schneider, Arne Schwindt

Panel:

Steven Kum, Roberto Ferraresi, Miguel Montero-Baker, Katja Mühlberg
1. FOCUS ON DEEP VENOUS ARTERIALIZATION
2. 15:45 - 15:50
  
  UCSF no-option patient identification rational and experience
3. 15:50 - 15:55
  
  Latest insights on DVA mechanism of action
4. 15:55 - 16:00
  
  When all hope seemed lost: My best cases of plantar vein arterialization using the LIMFLOW-procedure
5. 16:00 - 16:10
  
  Recorded LimFlow case
6. 16:10 - 16:15
  
  PROMISE I 24 month data
7. 16:15 - 16:20
  
  Post DVA procedural best practices with case examples
8. 16:20 - 16:25
  
  Post DVA wound care
9. 16:25 - 16:30
  
  Discussion
10. 16:30 - 16:55
  
  Live case transmission from Leipzig
11. 16:55 - 17:00
  
  Below-the-ankle vessel disease; when being aggressive, when being moderate and gentle, when not touching
12. 17:00 - 17:05
  
  Wound adjudication in CLTI/CLI trials
13. 17:05 - 17:10
  
  GLASS – global vascular guidelines: What are they and how valid are they in predicting outcomes in a comprehensive wound care program?
14. 17:10 - 17:15
  
  CLTI blueprints – establishing nov TOE, FLOW, and GO units of care
15. 17:15 - 17:30
  
  Discussion and conclusion

Notice

LINC 2022 Programme

LINC 2022 programme

Main Arena 1

New solutions for complex aortoiliac obstructions

Live case transmission from Leipzig – part I

Use and effectiveness of Pioneer re-entry device for subintimal true lumen re-entry: Single-centre data and a review of the literature

Initial interim results from the post-market registry of the GORE® VIABAHN® VBX balloon expandable endoprosthesis implanted in peripheral vessels

Following up patients with iliac occlusive disease treated with the GORE® VIABAHN® VBX balloon expandable endoprosthesis – FLEX clinical study

Outcomes of self-expanding e-PTFE covered stent when treating chronic iliac artery occlusions – a multi-centre experience

Live case transmission from Leipzig – part II

Versatility of covered stents in complex aorto-iliac POD lesions and FEVAR/BEVAR

FIRST TIME DATA RELEASE: BELSTREAM – 12-month results of study

5-year follow-up of CERAB reconstructions: Single center experience from the Netherlands

Multicentre experience on CERAB technique for the treatment option of AIOD – Polish experiences

Improving outcomes of vascular interventions with AI

Advances in intravascular imaging: Real world evidence and expert consensus

Opening Symposium: Focus on the lower limb: Novel treatment options from SFA to BTK

Welcome from the moderator

Late breaker: 2 year follow-up of SUPERSUB II

Discussion

THROMBECTOMY: THE BENEFITS OF MECHANICAL THROMBECTOMY FOR LOWER LIMB TREATMENT

Treating acute limb ischemia with mechanical thrombectomy – case presentation

Mechanical thrombectomy for venous thromboembolism: A pathway to consider?

Treating venous thromboembolism with mechanical thrombectomy – case presentation

Discussion

Tomorrow’s BTK treatment options – drug eluting resorbable scaffolds

Discussion

Take-home messages

Novel approaches and insights for treatment of complex femoropopliteal disease – part I

Serration angioplasty technique for better lumen gain

RECORDED CASE PRESENTATION: Serranator Serration balloon as primary therapy for CLTI disease

FIRST TIME DATA RELEASE: UltraScore – final results of a multi-center study

FIRST TIME DATA RELEASE: Long-term evidence of directonal atherectomy and DCB: 3-year clinical experience from Australia

Clinical outcomes with drug-coated balloon alone vs. drug-coated balloon plus provisional stenting: An analysis from the IN.PACT global study 5-year data

BIOPACT RCT: A head-to-head multicenter noninferiority trial of the safety and efficacy of Passeo-18 Lux vs. In.Pact Admiral DCBs in fempop lesions

Live case transmission from Bad Krozingen

FIRST TIME DATA RELEASE: Cost-effectiveness of urea excipient-based drug-coated balloons for chronic limb-threatening ischemia from femoropopliteal disease

5-year results from the Lutonix trial

IN.PACT global study 5-year diabetic and gender subgroup outcomes

Recent data outcomes in complex femoropopliteal occlusive disease with the GORE® VIABAHN® Endoprosthesis

Status of the SFA treatment paradigm

POLYMER-COATED DES: LEARN ABOUT THE EVIDENCE

Pre-clinical experience

Clinical experience

Clinical experience

Q&A, discussion

ADDITIONAL BENEFITS OF ENDOVASCULAR TREATMENT OVER BYPASS – READY TO MOVE ON?

Zilverpass – 36-month update and health economic snapshot

Should the endovascular approach be the new frontier?

Q&A, discussion, and conclusion

Novel approaches and insights for treatment of complex femoropopliteal disease – part II

Optimizing PTA following atherectomy in complex lower limb lesions: 12-month results of the DISSECT study

FIRST TIME DATA RELEASE: Treating common femoral artery steno-occlusive lesions with an endovascular approach using DA+DCB: 3-year follow-up in 75 patients

Live case transmission from Leipzig

Safety, effectiveness, and mid-term follow-up in 400 consecutive patients with moderate to severely calcified lesions undergoing phoenix atherectomy

Directional atherectomy (DA) followed by DCB to treat long, calcified femoropopliteal artery lesions: The REALITY study

EMINENT RCT (Eluvia vs. BMS): 12-month primary endpoint data and subset analysis

MIMICS-3D 3-year results: Compelling clinical outcomes with BioMimics 3D in complex patients and lesions

TINTIN trial 3-year follow-up

Live case transmission from Münster

FIRST TIME DATA RELEASE: Predictors of drug-coated balloon efficacy in femoropopliteal intervention: Insights from a patient-level pooled analysis

5-year results from the IN.PACT global study pre-specified cohorts: In-stent restenosis, chronic total occlusions, and long lesions

Safety and efficacy of Passeo-18 Lux in long lesions: Pooled results from the BIOLUX P-III and BIOLUX P-III Spain studies

Stellarex complex lesion subset analysis from the SAVER real world registry

CONNECT THE WORLD JAPAN: Pioneering approaches for CTO treatment in peripheral arteries

FLASH PRESENTATION: The results from CAPSICUM multi-center registry of Eluvia DES in Japan

FLASH PRESENTATION: IVUS for peripheral interventions: Basic knowledge and tips and tricks

First time right! Optimizing acute to long-term outcomes in lower limb revascularisation

Accurate assessment – see better to treat better

Optimized vessel preparation – plaque disruption, ablation, and removal

Definitive therapy – the importance of focal dissection repair

Live case transmission from Münster

Discussion and conclusion

Real-world catheter-based reperfusion strategies for the treatment of acute DVT and PE

Welcome and introduction

How I treat a patient presenting with iliofemoral DVT – rethro data on EKOS Angiojet

How I treat a patient presenting with pulmonary embolism – Zurich pathway

Present and future EKOS clinical data – KNOCOUT PE data and HiPeitho trial

Q&A, discussion, and conclusion